1Bellosta S,Ferri N,Bernini F,et al.Non-lipid-related effects of statins[J].J Annals of Medicine,2000,32(3):164-176.
2Youssef S,Stuve O,Patarroyo JC,et al.The HMG-CoA reductase inhibitor,atorvastatin,promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease[J].Nature,2002,420(6911):78-84.
3Stanislaus R,Pahan K,Singh AK,et al.Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin[J].Neurosci Lette,1999,269(2):71-74.
4Stanislaus R,Gilg AG,Singh AK,et al.Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin[J].Neurosci Lett,2002,333(3):167-170.
5Aktas O,Waiczies S,Smorodchenko A,et al.Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin[J].J Exp Med,2003,197(6):725-733.
6Nath N,Giri S,Prasad R,et al.Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy[J].J Immunol,2004,172(2),1273-1286.
7Dernellis,Panaretou M.Effect of O-reactive protein reduction on paroxysmal atrial fibrillation[J]. Am Heart J, 2005, 150(5):1064.
8Hanna IR,Heeke B,Bush H,et al.Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction[J]. Heart Rhythm, 2006,3(8): 881-886.
9Vyas AK,Guo H,Moss A J.et al.Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-Ⅱ [J]. J Am Coll Cardiol,2006,47(4): 767-773.
10McCarey DW,Melunes IB,Madhok R,et al.Trial of Atorvastatin in Rheumatoid Arthritis(TARA):double-blind,randomized placebo-contorlled trial[J]. Lancet, 2004,363:2015-2021.
